[ACRX] YoY Quarter Result on 31-Mar-2015 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
04-May-2015
Financial Year
2015
Quarter
31-Mar-2015 [#Q1]
Profit Trend
QoQ- 27.44%
YoY- -4.10%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Revenue 343 3,109 3,025 181 95 940 329 0.69%
PBT -11,592 -15,551 -10,979 -10,026 -9,631 -12,762 -7,065 8.59%
Tax 136 -2,704 2 806 -618 -1,285 519 -19.99%
NP -11,592 -15,551 -10,981 -10,026 -9,631 -12,762 -7,065 8.59%
Tax Rate - - - - - - - -
Total Cost 11,935 18,660 14,006 10,207 9,726 13,702 7,394 8.30%
Ratio Analysis
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
NP Margin -3,379.59 -500.19 -363.01 -5,539.23 -10,137.89 -1,357.66 -2,147.42 7.84%
Per Share
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
EPS -4.55 -6.86 -4.85 -4.57 -4.46 -6.87 -7.21 -7.38%
EPS Diluted -4.55 -6.86 -4.85 -4.51 -4.46 -6.87 -7.21 -7.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.